Having previously expressed an interest in getting his leg amputated for the purpose of a radical body modification, Whelan ...

The single-rod, etonogestrel-releasing, subdermal implant (ENG implant) is the most effective, long-acting reversible method of contraception available. The failure rate of the ENG implant is 0.05 ...

The trial investigates the safety, tolerability, and full pharmacokinetic profile of an exenatide implant. Vivani’s lead ...

subdermal implants based on its proprietary NanoPortal technology platform to enable long-term, near constant-rate delivery of a broad range of medicines to eliminate medication non-adherence ...

The 3 methods of long-term contraception (LTC) approved for use in the US are intrauterine devices (IUDs), levonorgestrel subdermal implants, and sustained-release medroxyprogesterone acetate ...

Presentation: Advancing Chronic Disease Management with Ultra Long-Acting Miniature Subdermal Implants of GLP-1 Presentation Date: Wednesday, December 11, 2024 Presentation Time: 4:20pm ...

The trial investigates the safety, tolerability, and full pharmacokinetic profile of an exenatide implant. Vivani’s lead program, NPM-115, utilizes a miniature, six-month, subdermal, GLP-1 ...

Vivani’s lead program, NPM-115, utilizes a miniature, six-month, subdermal, GLP-1 (exenatide) implant under development for chronic weight management in obese or overweight individuals.

Presentation: Advancing Chronic Disease Management with Ultra Long-Acting Miniature Subdermal Implants of GLP-1 Presentation Date: Wednesday, December 11, 2024 Presentation Time: 4:20pm, Pacific Time ...